Related Experiment Videos
IL-12 induces T helper 1-directed antitumor response
K Tsung1, J B Meko, G R Peplinski
1Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|April 1, 1997
Summary
Interleukin-12 (IL-12) triggers a Th1 cell response, utilizing macrophages and nitric oxide to eliminate established tumors. This immune activation requires a pre-existing host T cell response for effective tumor regression.
Area of Science:
- Immunology
- Cancer Biology
- Cytokine Signaling
Background:
- Interleukin-12 (IL-12) is recognized for its potent single-cytokine antitumor efficacy.
- The precise mechanisms underlying IL-12's antitumor activities have remained largely undefined.
- Understanding IL-12's action is crucial for developing effective cancer immunotherapies.
Purpose of the Study:
- To elucidate the mechanism by which IL-12 mediates its antitumor effects.
- To identify the key cellular and molecular components involved in IL-12-induced tumor regression.
- To determine the role of T helper 1 (Th1) cells and macrophages in IL-12's efficacy.
Main Methods:
- Utilized a complete tumor regression model induced by IL-12 treatment in mice.
- Assessed the role of macrophages and nitric oxide (NO) production via inducible nitric oxide synthase (iNOS).
- Investigated the impact of IL-12 on T cell cytokine profiles (IFN-gamma, IL-2, IL-4, IL-10) at the tumor site.
- Employed a nitric oxide synthase inhibitor in vivo to confirm NO's role.
Main Results:
- IL-12 treatment led to complete regression of established subcutaneous tumors.
- Tumor necrosis was associated with tumor-infiltrating activated macrophages expressing high levels of iNOS.
- Inhibition of nitric oxide synthase significantly delayed and reduced tumor regression.
- IL-12 induced a Th1 response, characterized by increased IFN-gamma and suppressed IL-2, IL-4, and IL-10 production by tumor-associated T cells.
Conclusions:
- The antitumor response induced by IL-12 is critically dependent on a Th1 cell-directed process.
- Activated macrophages producing nitric oxide serve as the primary effector cells in IL-12-mediated tumor rejection.
- IL-12 efficacy is contingent upon the presence of a host T cell response to the tumor prior to treatment, highlighting its role in orchestrating cell-mediated immunity against established tumors.